[1]
Khan, N.U. et al. 2025. IL28B (IFNL3) rs12979860 predicts response to interferon-α2a plus ribavirin in Pakistani adults with chronic hepatitis C: A longitudinal cohort study. International Journal of Pathology. 23, 4 (Dec. 2025), 410–418. DOI:https://doi.org/10.59736/IJP.23.04.1014.